Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)
2.62 x 2 2.70 x 5
Post-market by (Cboe BZX)
2.71 -0.12 (-4.24%) 04/04/25 [NASDAQ]
2.62 x 2 2.70 x 5
Post-market 2.62 -0.09 (-3.31%) 17:19 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.56
Day High
2.77
Open 2.76
Previous Close 2.83 2.83
Volume 1,501,700 1,501,700
Avg Vol 1,134,680 1,134,680
Stochastic %K 24.82% 24.82%
Weighted Alpha -72.22 -72.22
5-Day Change -0.23 (-7.82%) -0.23 (-7.82%)
52-Week Range 2.56 - 9.97 2.56 - 9.97
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 262,265
  • Shares Outstanding, K 92,673
  • Annual Sales, $ 0 K
  • Annual Income, $ -155,120 K
  • EBIT $ -178 M
  • EBITDA $ -178 M
  • 60-Month Beta 2.34
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.37

Options Overview Details

View History
  • Implied Volatility 261.08% ( +138.92%)
  • Historical Volatility 78.86%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 261.08% on 04/04/25
  • IV Low 31.44% on 08/22/24
  • Put/Call Vol Ratio 0.06
  • Today's Volume 362
  • Volume Avg (30-Day) 513
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 20,043
  • Open Int (30-Day) 22,343

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.47
  • Number of Estimates 4
  • High Estimate -0.34
  • Low Estimate -0.63
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +14.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.56 +5.86%
on 04/04/25
Period Open: 3.85
4.14 -34.54%
on 03/06/25
-1.14 (-29.61%)
since 03/04/25
3-Month
2.56 +5.86%
on 04/04/25
Period Open: 4.45
5.22 -48.08%
on 01/07/25
-1.74 (-39.10%)
since 01/03/25
52-Week
2.56 +5.86%
on 04/04/25
Period Open: 9.80
9.97 -72.82%
on 04/08/24
-7.09 (-72.35%)
since 04/04/24

Most Recent Stories

More News
Mind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay Bullish

The psychedelics treatment developer reported a net loss of $34.7 million for the quarter ended Dec. 31, 2024, widening from a $23.8 million loss a year earlier.

CMPS : 2.71 (-4.24%)
MNMD : 5.43 (-2.16%)
Compass Pathways Plc (CMPS) Q4 2024 Earnings Call Transcript

CMPS earnings call for the period ending December 31, 2024.

CMPS : 2.71 (-4.24%)
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months

Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.

CMPS : 2.71 (-4.24%)
ATAI : 1.3100 (-0.38%)
MNMD : 5.43 (-2.16%)
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?

Don't jump in without doing some research first.

CMPS : 2.71 (-4.24%)
AACG : 0.8801 (+1.69%)
MNMD : 5.43 (-2.16%)
CYBN : 5.69 (-4.53%)
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination

Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS). Vaccine stocks took a nosedive,...

CMPS : 2.71 (-4.24%)
PSIL : 10.69 (-3.30%)
ATAI : 1.3100 (-0.38%)
AZN : 68.46 (-7.39%)
BVNRY : 6.9000 (-6.82%)
NVAX : 6.24 (+11.43%)
MRNA : 25.11 (-2.41%)
CYBN : 5.69 (-4.53%)
GSK : 36.53 (-6.36%)
PFE : 22.97 (-5.43%)
BNTX : 88.05 (-4.30%)
SNY : 51.98 (-4.83%)
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript

CMPS earnings call for the period ending September 30, 2024.

CMPS : 2.71 (-4.24%)
Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript

CMPS earnings call for the period ending June 30, 2024.

CMPS : 2.71 (-4.24%)
1 Biotech Stock Under $10 That Could Surge 420%

Down 84% from all-time highs, Compass Pathways is a beaten-down biotech stock that trades at a massive discount to consensus price target estimates in 2024.

CMPS : 2.71 (-4.24%)
RY : 110.91 (-3.65%)
Should You Buy the Dip on Compass Pathways Stock?

Nothing is going wrong, but one of its peers just hit a serious snag.

CMPS : 2.71 (-4.24%)
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.

Regulators were not impressed by one company's petition for approval.

CMPS : 2.71 (-4.24%)

Business Summary

COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK.

See More

Key Turning Points

3rd Resistance Point 3.01
2nd Resistance Point 2.89
1st Resistance Point 2.80
Last Price 2.71
1st Support Level 2.59
2nd Support Level 2.47
3rd Support Level 2.38

See More

52-Week High 9.97
Fibonacci 61.8% 7.14
Fibonacci 50% 6.27
Fibonacci 38.2% 5.39
Last Price 2.71
52-Week Low 2.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades